NUCLEIC ACID OF ANTIGEN AND HEPATITIS B VIRUS (HBV) - ANVISA Registration 80155020042

Access comprehensive regulatory information for NUCLEIC ACID OF ANTIGEN AND HEPATITIS B VIRUS (HBV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80155020042 and manufactured by programa nacional de controle de qualidade ltda. The registration is held by programa nacional de controle de qualidade ltda with validity until Dec 18, 2033.

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including EXACT DIAGNOSTICS, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
1 Competitors
80155020042
Registration Details
ANVISA Registration Number: 80155020042
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

80155020042

25351040125202318

73302879000108

Company Information

Brazil
PT: BRASIL

Dates and Status

Dec 18, 2023

18/12/2033

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "NUCLEIC ACID OF ANTIGEN AND HEPATITIS B VIRUS (HBV)"